22,60
08-октября-24 12:37:26
15 мин. задержка
Акции
-1,60
-6,61%
Сегодняшний диапазон
22,48 - 26,15
ISIN
N/A
Источник
NASDAQ
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
30 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
16 сен 2024 16:05:00 Источник Nasdaq GlobeNewswire